NDC 49288-0253
Herring
Herring
Herring is a Intradermal; Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Herring.
| Product ID | 49288-0253_28463a0e-70af-4169-b592-df65f4f13a5f |
| NDC | 49288-0253 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | Herring |
| Generic Name | Herring |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | HERRING |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fish Proteins, Dietary [EXT] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0253-5
50 mL in 1 VIAL, MULTI-DOSE (49288-0253-5)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0253-3 [49288025303]
Herring INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0253-1 [49288025301]
Herring INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0253-2 [49288025302]
Herring INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0253-4 [49288025304]
Herring INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0253-5 [49288025305]
Herring INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-29 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HERRING | .05 g/mL |
Pharmacological Class
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Allergens [CS]
- Dietary Proteins [CS]
- Fish Proteins
- Dietary [EXT]
NDC Crossover Matching brand name "Herring" or generic name "Herring"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1222 | Herring | Herring |
| 36987-1223 | Herring | Herring |
| 36987-1224 | Herring | Herring |
| 36987-1225 | Herring | Herring |
| 49288-0253 | Herring | Herring |
Trademark Results [Herring]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HERRING 86232993 4860425 Live/Registered |
Ares Defense Systems, Inc. 2014-03-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.